Basel Medical Group Statistics
Total Valuation
BMGL has a market cap or net worth of $73.82 million. The enterprise value is $69.20 million.
| Market Cap | 73.82M |
| Enterprise Value | 69.20M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
BMGL has 18.46 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 18.46M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 22.33.
| PE Ratio | 22.33 |
| Forward PE | n/a |
| PS Ratio | 5.74 |
| Forward PS | n/a |
| PB Ratio | 14.49 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 59.30 |
| P/OCF Ratio | 58.97 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 20.93 |
| EV / Sales | 5.38 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 55.59 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 1.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | 4.13 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 36.77% and return on invested capital (ROIC) is 25.34%.
| Return on Equity (ROE) | 36.77% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 25.34% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | $415,040 |
| Profits Per Employee | $106,658 |
| Employee Count | 31 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BMGL had revenue of $12.87 million and earned $3.31 million in profits. Earnings per share was $0.18.
| Revenue | 12.87M |
| Gross Profit | 5.58M |
| Operating Income | 2.60M |
| Pretax Income | 1.87M |
| Net Income | 3.31M |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | $0.18 |
Full Income StatementBalance Sheet
The company has $9.77 million in cash and $5.15 million in debt, giving a net cash position of $4.62 million or $0.25 per share.
| Cash & Cash Equivalents | 9.77M |
| Total Debt | 5.15M |
| Net Cash | 4.62M |
| Net Cash Per Share | $0.25 |
| Equity (Book Value) | 5.10M |
| Book Value Per Share | 0.28 |
| Working Capital | n/a |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $1.25 million and capital expenditures -$7,044, giving a free cash flow of $1.24 million.
| Operating Cash Flow | 1.25M |
| Capital Expenditures | -7,044 |
| Free Cash Flow | 1.24M |
| FCF Per Share | $0.07 |
Full Cash Flow StatementMargins
Gross margin is 43.40%, with operating and profit margins of 20.18% and 25.70%.
| Gross Margin | 43.40% |
| Operating Margin | 20.18% |
| Pretax Margin | 14.56% |
| Profit Margin | 25.70% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | 9.67% |